FHL3 and gastric cancer: Previous studies have reported that FHL3 knockdown significantly inhibits the phosphorylation of the MAPK pathway components, including p38, ERK1/2, and JNK in gastric cancer cell lines, with FHL3 preventing substrate protein ubiquitination and degradation 33.